Compelling benefit of soluble suppression of tumorigenicity-2 in post-myocardial infarction estimation of risk: The time is right for its routine use in the clinic
- Díez, J.
- Bayes-Genis, A.
Revista:
Journal of the American Heart Association
ISSN: 2047-9980
Año de publicación: 2017
Volumen: 6
Número: 10
Tipo: Editorial
